|

nebulized ketamine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Ketalar

Pipeline

Phase 3: 1

Top Sponsors

  • Theresa Jacob, PhD, MPH1

Indications

  • GABA Agents1
  • GABA Modulators1
  • Anesthetics Agent1
  • Psychotropic Drugs1
  • Tranquilizing Agents1

Brooklyn, New York1 trial

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting

Maimonides Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.